Home > Back to Publisher > Report Information

OTC Healthcare in Saudi Arabia to 2011

Datamonitor
August 11, 2008
182 Pages - SKU: DFMN1872769

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Saudi Arabia

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Saudi Arabia. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in Saudi Arabia increased between 2001-2006, growing at an average annual rate of 12.6%.

The leading company in the market in 2006 was GlaxoSmithKline Plc. The second-largest player was Julphar with Tabuk Pharmaceutical Manufacturing Co. in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 EXECUTIVE SUMMARY
: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 3 MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
: GlaxoSmithKline Plc
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
: Value; Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
: Product launches over time; Recent product launches
Chapter 17 SAUDI ARABIA MACROECONOMIC PROFILE
: Macroeconomic Indicators
Chapter 18 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 19 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: Saudi Arabia OTC Healthcare value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 2: Saudi Arabia OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: Saudi Arabia OTC Healthcare company share, by value, 2005-2006 (%); Figure 4: Saudi Arabia Analgesics value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 5: Saudi Arabia Analgesics category growth comparison, by value, 2001-2011; Figure 6: Saudi Arabia Analgesics company share, by value, 2005-2006 (%); Figure 7: Saudi Arabia Cough and Cold Preparations value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 8: Saudi Arabia Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: Saudi Arabia Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 10: Saudi Arabia Traditional Medicines value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 11: Saudi Arabia First Aid Kits value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 12: Saudi Arabia First Aid Kits company share, by value, 2005-2006 (%); Figure 13: Saudi Arabia Indigestion Preparations value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 14: Saudi Arabia Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 15: Saudi Arabia Indigestion Preparations company share, by value, 2005-2006 (%); Figure 16: Saudi Arabia Vitamins and Minerals value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 17: Saudi Arabia Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 18: Saudi Arabia Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 19: Saudi Arabia Plasters & Bandages value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 20: Saudi Arabia Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 21: Saudi Arabia Plasters & Bandages company share, by value, 2005-2006 (%); Figure 22: Saudi Arabia Medicated Skin Products value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 23: Saudi Arabia Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 24: Saudi Arabia Medicated Skin Products company share, by value, 2005-2006 (%); Figure 25: Saudi Arabia Other OTC Healthcare Products value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 26: Saudi Arabia Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 27: Saudi Arabia Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 28: Saudi Arabia Topical OTC Medicines value & value forecast, 2001-2011 (SAR m, nominal prices); Figure 29: Saudi Arabia Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 30: Saudi Arabia Topical OTC Medicines company share, by value, 2005-2006 (%); Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 33: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: Saudi Arabia OTC Healthcare value, 2001-2006 (SAR m, nominal prices); Table 3: Saudi Arabia OTC Healthcare value forecast, 2006-2011 (SAR m, nominal prices); Table 4: Saudi Arabia OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: Saudi Arabia OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: Saudi Arabia OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: Saudi Arabia OTC Healthcare value, by brand 2005-2006 (SAR m nominal prices); Table 8: Saudi Arabia OTC Healthcare company share by value, 2005-2006 (%); Table 9: Saudi Arabia OTC Healthcare value, by company, 2005-2006 (SAR m nominal prices); Table 10: Saudi Arabia OTC Healthcare expenditure per capita, 2001-2006 (SAR, nominal prices); Table 11: Saudi Arabia OTC Healthcare forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 12: Saudi Arabia OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: Saudi Arabia OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: GlaxoSmithKline Plc Key Facts; Table 15: Saudi Arabia Analgesics value, 2001-2006 (SAR m, nominal prices); Table 16: Saudi Arabia Analgesics value forecast, 2006-2011 (SAR m, nominal prices); Table 17: Saudi Arabia Analgesics value, 2001-2006 (US$ m nominal prices); Table 18: Saudi Arabia Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 19: Saudi Arabia Analgesics brand share, by value, 2005-2006 (%); Table 20: Saudi Arabia Analgesics value, by brand 2005-2006 (SAR m nominal prices); Table 21: Saudi Arabia Analgesics company share by value, 2005-2006 (%); Table 22: Saudi Arabia Analgesics value, by company, 2005-2006 (SAR m nominal prices); Table 23: Saudi Arabia Analgesics expenditure per capita, 2001-2006 (SAR, nominal prices); Table 24: Saudi Arabia Analgesics forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 25: Saudi Arabia Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 26: Saudi Arabia Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 27: Saudi Arabia Cough and Cold Preparations value, 2001-2006 (SAR m, nominal prices); Table 28: Saudi Arabia Cough and Cold Preparations value forecast, 2006-2011 (SAR m, nominal prices); Table 29: Saudi Arabia Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 30: Saudi Arabia Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 31: Saudi Arabia Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 32: Saudi Arabia Cough and Cold Preparations value, by brand 2005-2006 (SAR m nominal prices); Table 33: Saudi Arabia Cough and Cold Preparations company share by value, 2005-2006 (%); Table 34: Saudi Arabia Cough and Cold Preparations value, by company, 2005-2006 (SAR m nominal prices); Table 35: Saudi Arabia Cough and Cold Preparations expenditure per capita, 2001-2006 (SAR, nominal prices); Table 36: Saudi Arabia Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 37: Saudi Arabia Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 38: Saudi Arabia Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 39: Saudi Arabia Traditional Medicines value, 2001-2006 (SAR m, nominal prices); Table 40: Saudi Arabia Traditional Medicines value forecast, 2006-2011 (SAR m, nominal prices); Table 41: Saudi Arabia Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 42: Saudi Arabia Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 43: Saudi Arabia Traditional Medicines brand share, by value, 2005-2006 (%); Table 44: Saudi Arabia Traditional Medicines value, by brand 2005-2006 (SAR m nominal prices); Table 45: Saudi Arabia Traditional Medicines company share by value, 2005-2006 (%); Table 46: Saudi Arabia Traditional Medicines value, by company, 2005-2006 (SAR m nominal prices); Table 47: Saudi Arabia Traditional Medicines expenditure per capita, 2001-2006 (SAR, nominal prices); Table 48: Saudi Arabia Traditional Medicines forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 49: Saudi Arabia Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 50: Saudi Arabia Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 51: Saudi Arabia First Aid Kits value, 2001-2006 (SAR m, nominal prices); Table 52: Saudi Arabia First Aid Kits value forecast, 2006-2011 (SAR m, nominal prices); Table 53: Saudi Arabia First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 54: Saudi Arabia First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 55: Saudi Arabia First Aid Kits brand share, by value, 2005-2006 (%); Table 56: Saudi Arabia First Aid Kits value, by brand 2005-2006 (SAR m nominal prices); Table 57: Saudi Arabia First Aid Kits company share by value, 2005-2006 (%); Table 58: Saudi Arabia First Aid Kits value, by company, 2005-2006 (SAR m nominal prices); Table 59: Saudi Arabia First Aid Kits expenditure per capita, 2001-2006 (SAR, nominal prices); Table 60: Saudi Arabia First Aid Kits forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 61: Saudi Arabia First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 62: Saudi Arabia First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 63: Saudi Arabia Indigestion Preparations value, 2001-2006 (SAR m, nominal prices); Table 64: Saudi Arabia Indigestion Preparations value forecast, 2006-2011 (SAR m, nominal prices); Table 65: Saudi Arabia Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 66: Saudi Arabia Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 67: Saudi Arabia Indigestion Preparations brand share, by value, 2005-2006 (%); Table 68: Saudi Arabia Indigestion Preparations value, by brand 2005-2006 (SAR m nominal prices); Table 69: Saudi Arabia Indigestion Preparations company share by value, 2005-2006 (%); Table 70: Saudi Arabia Indigestion Preparations value, by company, 2005-2006 (SAR m nominal prices); Table 71: Saudi Arabia Indigestion Preparations expenditure per capita, 2001-2006 (SAR, nominal prices); Table 72: Saudi Arabia Indigestion Preparations forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 73: Saudi Arabia Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 74: Saudi Arabia Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 75: Saudi Arabia Vitamins and Minerals value, 2001-2006 (SAR m, nominal prices); Table 76: Saudi Arabia Vitamins and Minerals value forecast, 2006-2011 (SAR m, nominal prices); Table 77: Saudi Arabia Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 78: Saudi Arabia Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 79: Saudi Arabia Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 80: Saudi Arabia Vitamins and Minerals value, by brand 2005-2006 (SAR m nominal prices); Table 81: Saudi Arabia Vitamins and Minerals company share by value, 2005-2006 (%); Table 82: Saudi Arabia Vitamins and Minerals value, by company, 2005-2006 (SAR m nominal prices); Table 83: Saudi Arabia Vitamins and Minerals expenditure per capita, 2001-2006 (SAR, nominal prices); Table 84: Saudi Arabia Vitamins and Minerals forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 85: Saudi Arabia Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 86: Saudi Arabia Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 87: Saudi Arabia Plasters & Bandages value, 2001-2006 (SAR m, nominal prices); Table 88: Saudi Arabia Plasters & Bandages value forecast, 2006-2011 (SAR m, nominal prices); Table 89: Saudi Arabia Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 90: Saudi Arabia Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 91: Saudi Arabia Plasters & Bandages brand share, by value, 2005-2006 (%); Table 92: Saudi Arabia Plasters & Bandages value, by brand 2005-2006 (SAR m nominal prices); Table 93: Saudi Arabia Plasters & Bandages company share by value, 2005-2006 (%); Table 94: Saudi Arabia Plasters & Bandages value, by company, 2005-2006 (SAR m nominal prices); Table 95: Saudi Arabia Plasters & Bandages expenditure per capita, 2001-2006 (SAR, nominal prices); Table 96: Saudi Arabia Plasters & Bandages forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 97: Saudi Arabia Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 98: Saudi Arabia Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 99: Saudi Arabia Medicated Skin Products value, 2001-2006 (SAR m, nominal prices); Table 100: Saudi Arabia Medicated Skin Products value forecast, 2006-2011 (SAR m, nominal prices); Table 101: Saudi Arabia Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 102: Saudi Arabia Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 103: Saudi Arabia Medicated Skin Products brand share, by value, 2005-2006 (%); Table 104: Saudi Arabia Medicated Skin Products value, by brand 2005-2006 (SAR m nominal prices); Table 105: Saudi Arabia Medicated Skin Products company share by value, 2005-2006 (%); Table 106: Saudi Arabia Medicated Skin Products value, by company, 2005-2006 (SAR m nominal prices); Table 107: Saudi Arabia Medicated Skin Products expenditure per capita, 2001-2006 (SAR, nominal prices); Table 108: Saudi Arabia Medicated Skin Products forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 109: Saudi Arabia Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 110: Saudi Arabia Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 111: Saudi Arabia Other OTC Healthcare Products value, 2001-2006 (SAR m, nominal prices); Table 112: Saudi Arabia Other OTC Healthcare Products value forecast, 2006-2011 (SAR m, nominal prices); Table 113: Saudi Arabia Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 114: Saudi Arabia Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 115: Saudi Arabia Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 116: Saudi Arabia Other OTC Healthcare Products value, by brand 2005-2006 (SAR m nominal prices); Table 117: Saudi Arabia Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 118: Saudi Arabia Other OTC Healthcare Products value, by company, 2005-2006 (SAR m nominal prices); Table 119: Saudi Arabia Other OTC Healthcare Products expenditure per capita, 2001-2006 (SAR, nominal prices); Table 120: Saudi Arabia Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 121: Saudi Arabia Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 122: Saudi Arabia Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 123: Saudi Arabia Topical OTC Medicines value, 2001-2006 (SAR m, nominal prices); Table 124: Saudi Arabia Topical OTC Medicines value forecast, 2006-2011 (SAR m, nominal prices); Table 125: Saudi Arabia Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 126: Saudi Arabia Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 127: Saudi Arabia Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 128: Saudi Arabia Topical OTC Medicines value, by brand 2005-2006 (SAR m nominal prices); Table 129: Saudi Arabia Topical OTC Medicines company share by value, 2005-2006 (%); Table 130: Saudi Arabia Topical OTC Medicines value, by company, 2005-2006 (SAR m nominal prices); Table 131: Saudi Arabia Topical OTC Medicines expenditure per capita, 2001-2006 (SAR, nominal prices); Table 132: Saudi Arabia Topical OTC Medicines forecast expenditure per capita, 2006-2011 (SAR, nominal prices); Table 133: Saudi Arabia Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 134: Saudi Arabia Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 135: Global OTC Healthcare market value, 2006; Table 136: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 137: Leading players - Top 5 countries; Table 138: Saudi Arabia OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006; Table 139: Saudi Arabia OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006; Table 140: Saudi Arabia OTC Healthcare new product launches (reports), by Package tags or Claims 2006; Table 141: Saudi Arabia OTC Healthcare new product launches (reports) - Recent 5 launches; Table 142: Saudi Arabia population, by age group, 2000-2005 (millions); Table 143: Saudi Arabia population forecast, by age group, 2005-2010 (millions); Table 144: Saudi Arabia population, by gender, 2000-2005 (millions); Table 145: Saudi Arabia population forecast, by gender, 2005-2010 (millions); Table 146: Saudi Arabia real GDP, 2000-2005 (SAR bn, 2005 prices); Table 147: Saudi Arabia real GDP forecast, 2005-2010 (SAR bn, 2005 prices); Table 148: Saudi Arabia nominal GDP, 2000-2005 (SAR bn, nominal prices); Table 149: Saudi Arabia real GDP, 2000-2005 (US$ bn, 2005 prices); Table 150: Saudi Arabia real GDP forecast, 2005-2010 (US$ bn, 2005 prices); Table 151: Saudi Arabia consumer price index, 2000-2005 (2000=100); Table 152: Saudi Arabia consumer price index, 2005-2010 (2000=100); Table 153: Saudi Arabia exchange rate, 2000-2005

More Saudi Arabia Over-the-Counter Drugs Reports

OTC Pharmaceuticals in Saudi Arabia by MarketLine
Introduction OTC Pharmaceuticals in Saudi Arabia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast ...

The Pharmaceutical Market: Saudi Arabia (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

Incontinence In Saudi Arabia by Euromonitor International
Incontinence products continued to benefit from a lessening of the taboos surrounding incontinence towards the end of the review period. There was widening awareness of ...

NRT Smoking Cessation Aids in Saudi Arabia by Euromonitor International
Several measures were introduced by the Saudi government to reduce the incidence of smoking during the review period. These included a ban on smoking in ...

Medicated Skin Care in Saudi Arabia by Euromonitor International
Continuing the trends seen in 2009, medicated shampoos and hair loss treatments were the only product categories to see current value sales decline in 2010. ...

See all reports like this >>

More Saudi Arabia Reports

Non-domestic Cooling, Ventilation and Other General Purpose Machinery in Saudi Arabia: ISIC 2919 by Euromonitor International
Euromonitor International's Industrial reports provide a 360 degree view of an industry. TheIndustrial market report offers a comprehensive guide to the size and shape of ...

Mining of Metal Ores in Saudi Arabia: ISIC 13 by Euromonitor International
Euromonitor International's Industrial reports provide a 360 degree view of an industry. TheIndustrial market report offers a comprehensive guide to the size and shape of ...

D&B Country RiskLine Report: Saudi Arabia by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: Saudi Arabia by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report Saudi Arabia January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

See all reports like this >>

OTC Healthcare in Saudi Arabia to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service